Cancer.Net Associate Editors share important new research from the 2018 ASCO Annual Meeting that can help improve the quality of life for people living with cancer.
head and neck cancer
ASCO Annual Meeting 2018: Geriatric Assessment Improves Communication, Racial and Gender Differences in Cancer Treatment, and a Comparison of Cancer Treatment Costs
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada.
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.
Dr. Kathryn Gold provides an overview of head and neck cancers, including risk factors, symptoms, diagnosis, treatment, and side effects.
In this podcast, registered dietitians Annette Goldberg and Maureen Gardner discuss ways to cope with side effects that can make eating difficult due to treatment for head and neck cancer.
In this podcast, Cancer.Net Specialty Editor Dr. Timothy Gilligan discusses some of the quality-of-life research featured at the 2018 Cancer Survivorship Symposium: Advancing Care and Research.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
Research Round Up Podcast: Brain Tumors, Childhood Cancer, Head and Neck Cancer, and Prostate Cancer
Listen to some of the most exciting research news from the 2017 ASCO Annual Meeting in this Research Round Up podcast.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
In this Voices on Cancer post, advocate Holly Boykin describes why building awareness of oral, head, and neck cancers can save lives and some of the tools she’s used to empower her advocacy career.